[BIO-B] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[BIO-B] Bio-Rad Laboratories, Inc.
Announcement Date
17-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 607.51%
YoY- 152.97%
Quarter Report
BIO-B's Result
BIO-B's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 681,184 730,288 732,769 789,839 624,428 617,541 620,433 1.56%
PBT 428,392 1,091,282 -2,038,055 1,078,533 699,430 -1,046,547 37,683 49.92%
Tax 78,684 263,548 -464,396 239,431 145,944 -213,400 -32,216 -
NP 349,708 833,494 -1,573,659 839,102 553,486 -833,147 69,899 30.76%
Tax Rate -18.37% -24.15% - -22.20% -20.87% - 85.49% -
Total Cost 331,476 -103,206 2,306,428 -49,263 70,942 1,450,688 550,534 -8.10%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 51.34 114.13 -214.76 106.24 88.64 -134.91 11.27 28.73%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 12.15 27.89 -52.59 28.13 18.50 -27.88 2.35 31.48%
EPS Diluted 12.14 27.78 -52.59 27.81 18.31 -27.88 2.32 31.74%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.